The Oncology Institute, Inc. (TOI)

The Oncology Institute Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	33.57	27.66	30.29	39.74	49.67	47.4	36.42	36.06	33.49	27.54	28.89	15.25	14.01	61.43	64.21	95.53	115.17	0.2	0.62	0.57
Short-Term Investments	-	-	-	-	-	-	9.94	29.78	49.37	59.88	10.29	40.13	59.8	29.15	-	-	-	-	-	-
Cash & Short-Term Investments	33.57	27.66	30.29	39.74	49.67	47.4	46.36	65.83	82.86	87.41	39.18	55.38	73.81	90.58	64.21	95.53	115.17	0.2	0.62	0.57
Cash Growth	-32.42%	-41.65%	-34.66%	-39.64%	-40.05%	-45.77%	18.32%	18.87%	12.26%	-3.50%	-38.98%	-42.03%	-35.92%	44114.00%	10243.93%	16563.00%	1820.21%	-79.48%	-43.73%	-61.97%
Accounts Receivable	59	59.64	55.66	49.32	48.34	54.5	54.02	58.76	42.36	48.44	46.39	45.96	39.82	34.82	28.95	24.51	20.01	-	-	-
Other Receivables	0.32	0.34	0.28	0.35	0.35	0.36	0.35	0.37	0.55	0.46	0.5	0.43	0.62	0.56	0.42	1.28	1.24	-	-	-
Total Trade Receivables	59.32	59.98	55.94	49.67	48.68	54.86	54.37	59.13	42.91	48.91	46.89	46.38	40.43	35.38	29.37	25.79	21.24	-	-	-
Inventory	16.88	18.88	15.79	12.31	10.04	10.11	11.32	11.55	13.68	12.17	12.17	10.25	9.26	10.02	8.58	7.77	6.44	-	-	-
Other Current Assets	2.99	3.57	2.78	5.11	4.03	4.06	4.16	4.68	4.05	4.19	5.83	6.94	6.92	7.66	10.05	10.74	11.2	230.09	230.13	230.46
Total Current Assets	112.75	110.09	104.79	106.82	112.42	116.43	116.21	141.19	143.49	152.68	104.07	118.96	130.42	143.63	112.21	139.84	154.06	0.29	747.18	736.16
Net Property, Plant & Equipment	33.06	33.98	34.74	35.33	37.67	39.36	39.22	38.41	40.05	39.32	39.81	34.52	33.04	31.81	23.27	22.14	4.19	-	-	-
Other Intangible Assets	11.02	11.73	12.45	14.04	14.81	15.58	16.36	17.13	17.9	18.56	19.34	17.23	17.96	18.67	19.38	17.57	18.25	-	-	-
Goodwill	7.23	7.23	7.23	7.23	7.23	7.23	7.23	7.23	7.23	7.23	7.23	4.55	21.42	31.02	34.48	26.63	26.63	-	-	-
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	58.94	58.84	58.35	58.22	-	-	-	-	-	-
Other Long-Term Assets	0.61	0.59	0.59	0.59	0.59	0.59	0.58	0.57	0.56	0.56	0.56	0.53	0.48	0.46	0.41	0.33	0.32	-	-	-
Total Assets	164.66	163.62	159.8	164	172.72	179.18	179.6	204.53	209.24	218.35	229.96	234.63	261.67	283.8	189.74	206.51	203.44	230.3	230.75	231.04
Accounts Payable	43.17	35.63	34.93	29.29	24.32	24.57	15.75	21.02	14.43	13.33	13.12	11.95	9.37	11.16	13.9	12.6	15.56	0.96	0.96	24.71
Accrued Expenses	20.64	22.79	22.89	23.43	21.09	15.44	12.83	18.36	14	12.98	14.38	12.5	14.85	16.53	17.74	14.65	14.06	2.67	1.56	0.15
Current Portion of Long-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.18	-	-	-
Current Portion of Leases	7.16	7.16	6.95	6.82	6.8	6.75	6.52	6.39	6.36	6.08	6	5.64	5.5	5.16	4.49	4.28	-	-	-	-
Total Current Liabilities	70.96	65.58	64.78	59.54	52.22	46.76	35.1	45.77	34.79	32.39	33.51	30.09	29.72	32.85	36.13	31.52	29.8	3.63	2.52	0.17
Long-Term Debt	77.4	76.2	75.02	73.89	93.13	91.54	89.95	88.39	86.83	85.25	83.69	82.14	80.62	79.07	-	-	-	-	-	-
Long-Term Leases	19.13	20.2	21.18	21.6	23.22	24.66	24.54	25.06	26.49	26.01	26.65	22.25	22.06	21.83	14.61	14.41	-	-	-	-
Other Long-Term Liabilities	12.88	13.92	7.8	3.9	0.56	0.74	0.81	4.02	4.12	2.85	1.4	1.75	6.09	22.12	15.02	28.58	69.48	21.57	22.71	19.21
Total Long-Term Liabilities	109.41	110.31	104.01	99.39	116.91	116.94	115.29	117.47	117.43	114.11	111.73	106.14	108.77	123.02	29.63	42.99	69.48	21.57	22.71	19.21
Total Liabilities	180.38	175.89	168.78	158.93	169.13	163.7	150.4	163.24	152.22	146.5	145.24	136.23	138.49	155.87	65.76	74.51	99.28	25.2	25.22	19.39
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0	0.01	0.01	0.01	0.01	0	0	0
Treasury Stock	-1.02	-1.02	-1.02	-1.02	-1.02	-1.02	-1.02	-1.02	-1.02	-1.02	-0.89	-	-	-	-	-	-	-	-	-
Additional Paid-in Capital	256.71	252.65	239.43	236.48	215.41	214.12	211.74	208.35	204.19	200.26	195.59	191.48	186.25	180	173.38	175.94	167.39	-	13.78	7.66
Retained Earnings	-271.42	-263.91	-247.41	-230.4	-210.81	-197.63	-181.52	-166.04	-146.15	-127.4	-109.98	-93.08	-63.08	-52.08	-49.4	-43.95	-63.23	-24.9	-8.78	-2.66
Total Common Shareholders' Equity	-15.72	-12.27	-8.99	5.07	3.59	15.48	29.21	41.3	57.03	71.85	84.72	98.41	123.17	127.93	123.98	132	104.16	-24.9	5	5
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	230	200.53	206.65
Shareholders' Equity	-15.72	-12.27	-8.99	5.07	3.59	15.48	29.21	41.3	57.03	71.85	84.72	98.41	123.17	127.93	123.98	132	104.16	205.1	205.53	211.65
Total Liabilities & Equity	164.66	163.62	159.8	164	172.72	179.18	179.6	204.53	209.24	218.35	229.96	234.63	261.67	283.8	189.74	206.51	203.44	230.3	230.75	231.04
Total Debt	103.69	103.55	103.16	102.31	123.15	122.95	121.01	119.84	119.68	117.35	116.34	110.03	108.18	106.06	19.1	18.69	0.18	0	0	0
Net Cash (Debt)	-70.12	-75.89	-72.86	-62.57	-73.48	-75.55	-74.64	-54	-36.82	-29.94	-77.15	-54.65	-34.37	-15.48	45.11	76.85	114.99	0.2	0.62	0.57
Net Cash Growth	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7166.92%	13303.80%	-	-79.48%	-43.73%	-61.97%
Net Cash Per Share	-0.69	-0.78	-0.78	-0.81	-0.97	-1.00	-1.00	-0.73	-0.50	-0.41	-1.04	-0.74	-0.40	-0.20	0.62	1.01	1.64	0.00	0.01	0.01
Book Value	-15.72	-12.27	-8.99	5.07	3.59	15.48	29.21	41.3	57.03	71.85	84.72	98.41	123.17	127.93	123.98	132	104.16	-24.9	5	5
Book Value Per Share	-0.15	-0.13	-0.10	0.07	0.05	0.20	0.39	0.56	0.78	0.97	1.14	1.34	1.44	1.61	1.70	1.73	1.49	-0.38	0.08	0.08
Tangible Book Value	-33.97	-31.24	-28.66	-16.2	-18.45	-7.33	5.62	16.94	31.89	46.06	58.15	76.63	83.79	78.25	70.12	87.8	59.29	-24.9	5	5
Tangible Book Value Per Share	-0.33	-0.32	-0.31	-0.21	-0.24	-0.10	0.08	0.23	0.43	0.62	0.78	1.04	0.98	0.98	0.96	1.15	0.85	-0.38	0.08	0.08

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q